SE8604445D0 - Nya peptider och tillempningar derav - Google Patents

Nya peptider och tillempningar derav

Info

Publication number
SE8604445D0
SE8604445D0 SE8604445A SE8604445A SE8604445D0 SE 8604445 D0 SE8604445 D0 SE 8604445D0 SE 8604445 A SE8604445 A SE 8604445A SE 8604445 A SE8604445 A SE 8604445A SE 8604445 D0 SE8604445 D0 SE 8604445D0
Authority
SE
Sweden
Prior art keywords
arg
thr
glu
tyr
val
Prior art date
Application number
SE8604445A
Other languages
English (en)
Other versions
SE455946B (sv
SE8604445L (sv
Inventor
T Bartfai
Original Assignee
Trion Forskning & Utveckling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trion Forskning & Utveckling filed Critical Trion Forskning & Utveckling
Priority to SE8604445A priority Critical patent/SE455946B/sv
Publication of SE8604445D0 publication Critical patent/SE8604445D0/sv
Priority to US07/346,837 priority patent/US5225193A/en
Priority to EP87850312A priority patent/EP0266325B1/en
Priority to DE8787850312T priority patent/DE3781863T2/de
Priority to AT87850312T priority patent/ATE80895T1/de
Priority to PCT/SE1987/000476 priority patent/WO1988002754A1/en
Priority to JP62506690A priority patent/JP2635641B2/ja
Priority to IE872802A priority patent/IE872802L/xx
Priority to AU81524/87A priority patent/AU624066B2/en
Priority to PT85960A priority patent/PT85960B/pt
Publication of SE8604445L publication Critical patent/SE8604445L/sv
Priority to DK312088A priority patent/DK312088A/da
Priority to NO882709A priority patent/NO882709D0/no
Publication of SE455946B publication Critical patent/SE455946B/sv
Priority to FI891872A priority patent/FI891872A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8604445A 1986-10-20 1986-10-20 Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner SE455946B (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8604445A SE455946B (sv) 1986-10-20 1986-10-20 Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner
EP87850312A EP0266325B1 (en) 1986-10-20 1987-10-19 Bordetella pertussis polypeptides and toxin antigens
JP62506690A JP2635641B2 (ja) 1986-10-20 1987-10-19 新規ペプチド類及びその用途
AU81524/87A AU624066B2 (en) 1986-10-20 1987-10-19 New peptides and applications thereof
DE8787850312T DE3781863T2 (de) 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene.
AT87850312T ATE80895T1 (de) 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene.
PCT/SE1987/000476 WO1988002754A1 (en) 1986-10-20 1987-10-19 New peptides and applications thereof
US07/346,837 US5225193A (en) 1986-10-20 1987-10-19 Bordetella toxin peptides and vaccines
IE872802A IE872802L (en) 1986-10-20 1987-10-19 New pep£tides and applications thereof
PT85960A PT85960B (pt) 1986-10-20 1987-10-20 Processo para a preparacao de novos peptidos e suas aplicacoes
DK312088A DK312088A (da) 1986-10-20 1988-06-08 Hidtil ukendte peptider og anvendelser deraf
NO882709A NO882709D0 (no) 1986-10-20 1988-06-17 Nye peptider og anvendelse derav.
FI891872A FI891872A (fi) 1986-10-20 1989-04-19 Nya peptider och anvaendning daerav.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8604445A SE455946B (sv) 1986-10-20 1986-10-20 Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner

Publications (3)

Publication Number Publication Date
SE8604445D0 true SE8604445D0 (sv) 1986-10-20
SE8604445L SE8604445L (sv) 1988-04-21
SE455946B SE455946B (sv) 1988-08-22

Family

ID=20365987

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604445A SE455946B (sv) 1986-10-20 1986-10-20 Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner

Country Status (12)

Country Link
US (1) US5225193A (sv)
EP (1) EP0266325B1 (sv)
JP (1) JP2635641B2 (sv)
AT (1) ATE80895T1 (sv)
AU (1) AU624066B2 (sv)
DE (1) DE3781863T2 (sv)
DK (1) DK312088A (sv)
FI (1) FI891872A (sv)
IE (1) IE872802L (sv)
PT (1) PT85960B (sv)
SE (1) SE455946B (sv)
WO (1) WO1988002754A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279151B1 (en) * 1986-12-22 1993-04-28 Trion Forskning- Och Utvecklings Aktiebolag Pertussis toxin polypeptide and its uses
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine
IT1229766B (it) * 1989-05-19 1991-09-10 Sclavo Spa Peptidi sintetici capaci di stimolare una immunita' t cellulare.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
SI3231444T1 (sl) 2014-05-12 2020-04-30 Verona Pharma Plc Novo zdravljenje

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019733B2 (ja) * 1977-06-10 1985-05-17 科研製薬株式会社 蛋白質性活性物質
JPS5767592A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein having reassociating properties and its preparation
JPS5767591A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein element substance and its preparation
JPS58222032A (ja) * 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
EP0279151B1 (en) * 1986-12-22 1993-04-28 Trion Forskning- Och Utvecklings Aktiebolag Pertussis toxin polypeptide and its uses
EP0362278A4 (en) * 1987-06-05 1990-05-14 Us Health FACTORS OF AUTOCRINE MOTILITY IN THE DIAGNOSIS AND TREATMENT OF CANCER.
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine

Also Published As

Publication number Publication date
IE872802L (en) 1988-04-20
AU8152487A (en) 1988-05-06
US5225193A (en) 1993-07-06
SE455946B (sv) 1988-08-22
DK312088A (da) 1988-08-10
WO1988002754A1 (en) 1988-04-21
FI891872A0 (fi) 1989-04-19
ATE80895T1 (de) 1992-10-15
PT85960B (pt) 1990-07-31
DE3781863T2 (de) 1993-03-11
JP2635641B2 (ja) 1997-07-30
FI891872A (fi) 1989-04-19
PT85960A (en) 1987-11-01
DE3781863D1 (de) 1992-10-29
EP0266325A1 (en) 1988-05-04
EP0266325B1 (en) 1992-09-23
AU624066B2 (en) 1992-06-04
DK312088D0 (da) 1988-06-08
SE8604445L (sv) 1988-04-21
JPH02500977A (ja) 1990-04-05

Similar Documents

Publication Publication Date Title
SE8704185L (sv) Nya peptider, artificiella antigener och immunoanalystestsatser
DE3688246D1 (de) Kunstpolypeptide zum nachweis mykobakterieller infektionen.
ATE319091T1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
DK460882A (da) Dna-sekvens, der koder for humant immun-interferon, replicerbareudtrykkelsesmedier herfor, mikroorganisme- eller cellekulturer transformeret med saadanne og fremgangsmaade til fremstilling af et polypeptid, der omfatter aminosyresekvensen af humant immun-interferon
DE3881204D1 (de) Molekuele mit mindestens einer peptidsequenz einer oder mehrerer epitopen eines p.falciparum-produzierten proteins in hepatozyten und zusammensetzungen davon.
KR910000604A (ko) 디에틸렌트리아민 펜타아세트산 유도체
SE8604445L (sv) Nya peptider och tillempningar derav
ES2133269T3 (es) Gen receptor del factor de crecimiento derivado de plaquetas de tipo oc.
DK232988D0 (da) Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE116660T1 (de) Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.
ES2080955T3 (es) Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos.
FI913714A0 (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
IT1241003B (it) Procedimento per la purificazione di un polipeptide ricombinante hdag equivalente, polipeptide hdag equivalente e saggi immunologici che lo utilizzano
KR910005887A (ko) 면역원성 물질의 고-보존된 아미노산 서열에 대한 항체, 이의 항체의 제조 방법 및 면역 감정에서의 이의 용도
JPS6490197A (en) Peptide
Pearson Immuno-taxonomic relationships among families of snakes
GR1000377B (el) Νεα πρωτεινη αναγνωρισεως της κυησεως σε θηλαστικα εφαρμογες στην προωρη ανιχνευση της κυησεως και μεθοδος παρασκευης της εν λογω πρωτεινης.
Kehoe Evolutionary Divergence of Immunoglobulin Constant Region Genes

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8604445-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8604445-0

Format of ref document f/p: F